Anaptysbio ANAB
NASDAQ ANAB
$48.68 +0.05 (+0.10%)
As of: Oct 2, 2026 · 11:21 AM EDT

Anaptysbio (ANAB) Non Operating Interest Expenses (2016 - 2019)

Updated

Anaptysbio (ANAB) reported Non Operating Interest Expenses of $200,000 for Q4 2019, down 45.2% from $365,000 a year earlier and down 16.7% from the prior quarter.

Analysis

Anaptysbio (ANAB) Non Operating Interest Expenses (2016 - 2019) Analysis & Trends

For FY2019, Anaptysbio posted Non Operating Interest Expenses of $1.04 million, down 37.0% from FY2018.

  • Non Operating Interest Expenses has a four-year compound annual growth rate of 22.7% (FY2015 to FY2019).
  • By year, Non Operating Interest Expenses came in at $1.65 million in FY2018 (-6.9%), $1.78 million in FY2017 (+287.6%), $458,000 in FY2016 (-0.4%) and $460,000 in FY2015.
  • The Q4 2019 figure ranks as the lowest quarterly Non Operating Interest Expenses since Q4 2016.
  • Year over year, Non Operating Interest Expenses has now declined in each of the last seven quarters, with an average decline of 22.1% over the last eight quarters.
  • The high point for year-over-year Non Operating Interest Expenses in five years was Q4 2017 (growth of 310.8%); the low point was Q4 2019 (a decline of 45.2%).
  • Per Business Quant data, the three quarters before Q4 2019 came in at $240,000 (Q3 2019), $281,000 (Q2 2019) and $320,000 (Q1 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Anaptysbio 1.46 Bn 346.34 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 200,000.00
Sep 30, 2019 240,000.00
Jun 30, 2019 281,000.00
Mar 31, 2019 320,000.00
Dec 31, 2018 365,000.00
Sep 30, 2018 400,000.00
Jun 30, 2018 436,000.00
Mar 31, 2018 451,000.00
Dec 31, 2017 456,000.00
Sep 30, 2017 452,000.00
Jun 30, 2017 439,000.00
Mar 31, 2017 428,000.00
Dec 31, 2016 111,000.00
Sep 30, 2016 116,000.00
Jun 30, 2016 116,000.00
Mar 31, 2016 115,000.00
API Access

Anaptysbio Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ANAB&period=max&api_key=YOUR_API_KEY